Journal article
Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules
Abstract
BACKGROUND: One schedule for the capsular group B meningococcal vaccine 4CMenB is 2 doses that are administered 2 months apart for children aged 12-23 months, with a booster dose 12-24 months later. Our objective was to provide data on persistence of human serum bactericidal antibody (hSBA) titres in children up to 4 years of age after initial doses at 12-24 months, and immunogenicity of a booster dose at 48 months of age compared with …
Authors
Sadarangani M; Sell T; Iro MA; Snape MD; Voysey M; Finn A; Heath PT; Bona G; Esposito S; Diez-Domingo J
Journal
Canadian Medical Association Journal, Vol. 189, No. 41, pp. e1276–e1285
Publisher
Joule
Publication Date
October 16, 2017
DOI
10.1503/cmaj.161288
ISSN
0820-3946